MDT logo
MDT@NYSE
Medtronic Plc
$ 88.48+0.73 (+0.83%)
Buy MDT
OpenPrice at market open
—
LowLowest price today
—
52-Week HighHighest past 52 weeks
—
HighHighest price today
—
52-Week LowLowest past 52 weeks
—
Market Cap.Total company value
112.32B
Today’s VolumeShares traded today
105.66M
Avg. VolumeAverage shares traded
11.36M
P/E RatioPrice to earnings ratio
21.45

Company Profile

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

IPO Date
1973-05-02
Headquarters
Galway, IE
CEO
Geoffrey Straub Martha
Sector
Healthcare
Industry
Medical - Devices

Financial Statements

Earnings

Related Companies

688617.SS logo
688617.SSAPT Medical Inc.
242.85
AVR logo
AVRAnteris Technologies Global Corp.
6.77
BSX logo
BSXBoston Scientific Corporation
42.73
EW logo
EWEdwards Lifesciences Corporation
85.21

Unlok the Future of Trading

Seamless access to global markets with AI-powered insights for smarter, more confident trading.

Device mockup